A ONECUT1 regulatory, non-coding region in pancreatic development and diabetes

In a patient with permanent neonatal syndromic diabetes clinically similar to cases with ONECUT1 biallelic mutations, we identified a disease-causing deletion located upstream of ONECUT1. Through genetic, genomic, and functional studies, we identified a crucial regulatory region acting as an enhancer of ONECUT1 specifically during pancreatic development. This enhancer region contains a low-frequency variant showing a strong association with type 2 diabetes and other glycemic traits, thus extending the contribution of this region to common forms of diabetes. Clinical relevance is provided by experimentally tailored therapy options for patients carrying ONECUT1 coding or regulatory mutations.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2024-10-19
DOI
https://doi.org/10.1016/j.celrep.2024.114853
Citations
2
Primary Topic
Pancreatic function and diabetes
Type
article
Field-Weighted Citation Impact
1.15

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A ONECUT1 regulatory, non-coding region in pancreatic development and diabetes

David Alexander Christian Messerer, Markus Breunig, Sandra Heller, Martin Heni et al.
2 citations
Cell Reports
Pancreatic function and diabetes
1.15
article

A ONECUT1 regulatory, non-coding region in pancreatic development and diabetes

David Alexander Christian Messerer, Markus Breunig, Sandra Heller, Martin Heni, Meike Hohwieler, Eduardo Gade Gusmao, Fernando Álvarez Guisasola, Anne Philippi, Chantal Allgöwer, Rupert Öllinger, Marita Führer, Cosima Drewes, Valérie Senée, Alexander Kleger, Franz Oswald, Ivan G. Costa, Cécile Julier, Sarah K. Merz, Roland Rad, Reiner Siebert, Martin Wagner, Franziska Birkhofer, Mina Shaigan, Jean-François Deleuze, Anne Boland
article en
2 citations

Abstract

In a patient with permanent neonatal syndromic diabetes clinically similar to cases with ONECUT1 biallelic mutations, we identified a disease-causing deletion located upstream of ONECUT1. Through genetic, genomic, and functional studies, we identified a crucial regulatory region acting as an enhancer of ONECUT1 specifically during pancreatic development. This enhancer region contains a low-frequency variant showing a strong association with type 2 diabetes and other glycemic traits, thus extending the contribution of this region to common forms of diabetes. Clinical relevance is provided by experimentally tailored therapy options for patients carrying ONECUT1 coding or regulatory mutations.

Cell ReportsVol. 43(11)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Universität Ulm (DE), Université Paris Cité (FR), Universidade Federal de Pernambuco (BR), Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR), Université Paris-Saclay (FR), German Red Cross (DE), Centre Hospitalier Universitaire Sainte-Justine (CA), Centre National de Recherche en Génomique Humaine (FR), Immungenetics (Germany) (DE), CEA Paris-Saclay (FR), Institut Cochin (FR), University Hospital Ulm (DE), Technical University of Munich (DE), University of Tübingen (DE), RWTH Aachen University (DE)
European Foundation for the Study of Diabetes, Deutsche Forschungsgemeinschaft, Agence Nationale de la Recherche, Else Kröner-Fresenius-Stiftung, Novo Nordisk, Hospices Civils de Lyon, Universität Ulm, Assistance publique-Hôpitaux de Paris
Openalex Percentile: Top 20%
Pancreatic function and diabetes
1.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.